MODERN APPROACHES AND IMMUNE PROFILE IN WOMEN WITH MISCARRIAGE
Schlagwörter:
hormonal receptors, ozone therapy, endometrium, miscarriageAbstract
Miscarriage is a serious problem, affecting up to 15-20% of all pregnancies. Women with a previous miscarriage have a significantly higher risk of recurrent miscarriage, making predicting pregnancy outcomes an extremely important aspect to minimize complications. This article presents modern forecasting methods based on our own research data.
Literaturhinweise
Aylamazyan E.K., Radzinsky V.E. Prevention of complications in early pregnancy, Cyber Leninka, 2020.https://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-prichinah-nevynashivaniya-beremennosti
Grigushkina E.V., Malyshkina A.I. Pathogenetic aspects of habitual miscarriage, Cyber Leninka, 2020.https://cyberleninka.ru/article/n/patogeneticheskie-aspekty-privychnogo-nevynashivaniya-beremennosti
Mikhalev S.A., Radzinsky V.E., Masalimova D.N. Risk of habitual miscarriage // Obstetrics and Gynecology: news, opinions, training. 2024. Vol. 12, No. 3. P. 20-25. DOI: https://doi.org/10.33029/2303-9698-2024-12-3-20-25
Dobrokhotova Yu.E., Kuznetsov P.A., Dzhokhadze L.S. Habitual miscarriage. Relevant today (ESHRE Protocol 2023, National Clinical Guidelines "Habitual Miscarriage" 2021, Proceedings of the ESHRE World Congress 2023). RMJ. Mother and Child. 2023;6(3):219–225. DOI: 10.32364/2618-8430-2023-6-3-1
Radzinsky V. E. Habitual miscarriage: a social problem and medical solutions, CyberLeninka, 2021. https://cyberleninka.ru/article/n/privychnoe-nevynashivanie-beremennosti-sotsialnaya-problema-meditsinskie-resheniya
ESHRE Guideline Group on RPL; Bender Atik R., Christiansen O. B. et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002. DOI: 10.1093/hropen/hoad002.
